These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36454255)

  • 1. [Thrombotic microangiopathies in surgical intensive care medicine with special consideration of atypical hemolytic uremic syndrome].
    Albrecht S; Kamla CE; Schönermarck U; Wassilowsky D
    Anaesthesiologie; 2023 Jan; 72(1):3-12. PubMed ID: 36454255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HUS and TTP: traversing the disease and the age spectrum.
    Donadelli R; Sinha A; Bagga A; Noris M; Remuzzi G
    Semin Nephrol; 2023 Jul; 43(4):151436. PubMed ID: 37949684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Differentiation of Shiga Toxin-Associated Hemolytic Uremic Syndrome in Critically Ill Adults With Thrombotic Microangiopathy Syndromes.
    Joseph A; Rafat C; Zafrani L; Mariani-Kurkdjian P; Veyradier A; Hertig A; Rondeau E; Mariotte E; Azoulay E
    Crit Care Med; 2018 Sep; 46(9):e904-e911. PubMed ID: 29979220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The complex differential diagnosis between thrombotic thrombocytopenic purpura and the atypical hemolytic uremic syndrome: Laboratory weapons and their impact on treatment choice and monitoring.
    Mannucci PM; Cugno M
    Thromb Res; 2015 Nov; 136(5):851-4. PubMed ID: 26386489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical hemolytic uremic syndrome (aHUS): essential aspects of an accurate diagnosis.
    Laurence J; Haller H; Mannucci PM; Nangaku M; Praga M; Rodriguez de Cordoba S
    Clin Adv Hematol Oncol; 2016 Nov; 14 Suppl 11(11):2-15. PubMed ID: 27930620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic approach to microangiopathic hemolytic disorders.
    Kottke-Marchant K
    Int J Lab Hematol; 2017 May; 39 Suppl 1():69-75. PubMed ID: 28447417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of microangiopathic hemolytic anemia].
    Morishita E
    Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
    Laurence J
    Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic-therapeutic algorithm for thrombotic microangiopathy. A report of two cases.
    Rubio-Haro R; Quesada-Carrascosa M; Hernández-Laforet J; Ferrer Gómez C; De Andrés J
    Rev Esp Anestesiol Reanim (Engl Ed); 2022 Mar; 69(3):179-182. PubMed ID: 35283062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report.
    Nieto-Rios JF; Zuluaga-Quintero M; Valencia-Maturana JC; Bello-Marquez DC; Aristizabal-Alzate A; Zuluaga-Valencia GA; Serna-Higuita LM; Arias LF
    J Bras Nefrol; 2021; 43(4):591-596. PubMed ID: 33179720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
    Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
    Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.
    Shenkman B; Einav Y
    Autoimmun Rev; 2014; 13(4-5):584-6. PubMed ID: 24418304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.
    Nakayama S; Hirashio S; Yorishima H; Doi T; Yoshida Y; Matsumoto M; Masaki T
    CEN Case Rep; 2019 Nov; 8(4):266-270. PubMed ID: 31177384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia.
    George JN; Charania RS
    Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CME: Diagnostic Approach and Management of Thrombotic Microangiopathy].
    Sutter T; Fehr T; Venzin R
    Praxis (Bern 1994); 2022; 111(14):771-777. PubMed ID: 36285415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and treatment of TMA based on Japanese clinical guides].
    Wada H; Hasegawa K; Watanabe M
    Rinsho Ketsueki; 2017; 58(7):849-856. PubMed ID: 28781284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombotic Thrombocytopenic Purpura and Atypical Hemolytic Uremic Syndrome Microangiopathy in Pregnancy.
    Scully M
    Semin Thromb Hemost; 2016 Oct; 42(7):774-779. PubMed ID: 27648610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.